NCT01330862View on ClinicalTrials.gov

Epidemiological Study to Describe Non-small-cell Lung Carcinoma (NSCLC) Clinical Management Patterns in MENA. Lung-EPICLIN/ KSA

UnknownOBSERVATIONAL
Enrollment

54

Participants

Timeline

Start Date

April 30, 2011

Primary Completion Date

March 31, 2013

Study Completion Date

March 31, 2013

Conditions
NSCLC Patient Characteristics
Trial Locations (4)

Unknown

Research Site, Qassim

Research Site, Riyadh

Research Site, Dammam

Research Site, Jeddah

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY